Prevention of Nosocomial Bacteremia Among Zambian Neonates

NACompletedINTERVENTIONAL
Enrollment

9,410

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

April 15, 2017

Study Completion Date

July 31, 2017

Conditions
Neonatal SepsisNeonatal Mortality
Interventions
DRUG

Chlorhexidine gluconate (CHG)

All enrolled neonates admitted to the NICU during the implementation and intervention periods will undergo CHG bathing (sparing head and face) at the time of admission at and thereafter once weekly.

BEHAVIORAL

Hand hygiene (HH)

Alcohol hand rub will be produced in the hospital pharmacy and will be readily available in the NICU (via wall-mounted dispensers) throughout the intervention period. Hand hygiene among NICU physicians and nurses will actively be promoted through the intervention period.

BEHAVIORAL

Infection control training

All NICU healthcare workers will receive infection prevention training which will involve structure training on HH, universal precautions, neonatal skin antisepsis and peripheral IV placement and line care.

OTHER

Infection control reminders via SMS text

Infection control practice reminders will be sent to NICU healthcare workers on a daily basis via SMS messages.

Trial Locations (1)

10101

University Teaching Hospital, Lusaka

All Listed Sponsors
collaborator

University Teaching Hospital, Lusaka, Zambia

OTHER

collaborator

Zambia Center for Applied Health Research and Development

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

lead

Boston University

OTHER

NCT02386592 - Prevention of Nosocomial Bacteremia Among Zambian Neonates | Biotech Hunter | Biotech Hunter